Gov’t Official Says Coronavirus Vaccine Clinical Trials Begin Today
CORONAVIRUS – US official said the clinical trial for novel coronavirus will begin today.
The novel coronavirus (COVID-19) was first reported in Wuhan City, China. The virus has sickened more than 150,000 people and left more than 5,000 dead.
The COVID-19 caused only mild to moderate symptoms such as cough and fever. It can cause more severe illness, especially to older adults.
Research groups around the world are doing their best to create a vaccine as coronavirus cases continue to grow. Some scientists created a temporary vaccine that might guard the health of the people.
Based on a report from Manila Times, a government official in Washington DC said the trial for the coronavirus vaccine will start on Monday, March 16. The clinical trial for a vaccine to protect against COVID-19 is funded by the National Institutes of Health.
According to the report, the clinical trial will be at the Kaiser Permanente Washington Health Research Institute in Seattle. The government official who disclosed the vaccine trial spoke on condition of anonymity because the plan was not announced publicly.
The validation of the shots co-developed by NIH and Moderna INC. will take a year to 18 months said the Public Health officials.
Based on the report, the vaccine trial will begin with 45 volunteers. They will receive different doses of shots.
These young and healthy participants could not get infected from the shots because they are not infected with the virus. The goal of the research group is to purely check of the vaccines who no side effects.
What can you say about this article? Leave your comments and reactions below.
READ ALSO: After Testing Delays, US COVID-19 Cases Rise